| mRNA |
Cytarabine |
CTRPv2 |
pan-cancer |
AAC |
0.22 |
6e-14 |
| mRNA |
3-Cl-AHPC |
CTRPv2 |
pan-cancer |
AAC |
0.23 |
4e-11 |
| mRNA |
ciclopirox |
CTRPv2 |
pan-cancer |
AAC |
0.2 |
2e-09 |
| mRNA |
pac-1 |
CTRPv2 |
pan-cancer |
AAC |
0.21 |
6e-09 |
| mRNA |
carboplatin:etoposide (40:17 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.17 |
1e-08 |
| mRNA |
tanespimycin:gemcitabine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.19 |
2e-08 |
| mRNA |
clofarabine |
CTRPv2 |
pan-cancer |
AAC |
0.17 |
2e-08 |
| mRNA |
Mitomycin-C |
CTRPv2 |
pan-cancer |
AAC |
0.19 |
4e-08 |
| mRNA |
CD-437 |
CTRPv2 |
pan-cancer |
AAC |
0.18 |
6e-08 |
| mRNA |
LY-2183240 |
CTRPv2 |
pan-cancer |
AAC |
0.18 |
6e-08 |